News & Events
September 9, 2019 - September 10, 2019
Solutions to Drug Development Challenges Workshop: Utilizing Quantitative Approaches, Data Sharing, and Novel BiomarkersTitle Presenter Presentation Link Introduction Dr. John-Michael Sauer (C-Path) Keynote Address Dr. Joseph Scheeren (C-Path) Welcoming Remarks Dr. Janet Woodcock (US FDA) Session 2: Benefits of DDT progression to regulatory acceptance Moderators: Dr. Inish O’Doherty (C-Path) and Dr. Ameeta Parekh (US FDA) 2.1 A perspective on the history and evolution of drug development......
September 27, 2018 - September 28, 2018
Workshop on Evidence-Based Treatment Decisions in Transplantation Informs PRO and Patient-Focused Drug DevelopmentThe U.S. Food and Drug Administration (FDA) held a public workshop on September 27-28, 2018 at its White Oak Campus in Silver Spring, MD. titled “Evidence-Based Treatment Decisions in Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment.” The workshop was planned and presented in collaboration with the Transplant Therapeutics Consortium (TTC),......